XTL Biopharmaceuticals Ltd ADR (XTLB) — Capital Reinvestment Ratio

Latest as of December 2019: 0.04x

XTL Biopharmaceuticals Ltd ADR (XTLB) has a Capital Reinvestment Ratio of 0.04x as of December 2019, meaning it reinvests 0% of its operating cash flow ($1.44 Million) in capital expenditures ($64.00K). See XTL Biopharmaceuticals Ltd ADR free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$1.44 Million

USD

Capital Expenditures

$64.00K

USD

Data as of

Dec 2019

Most recent filing

Annual Capital Reinvestment Ratio for XTL Biopharmaceuticals Ltd ADR (None–None)

Year-by-year Capital Reinvestment Ratio for XTL Biopharmaceuticals Ltd ADR from None to None. For live market cap and broader valuation context, see XTLB stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow